Sheng‐Long Ye

1 ta ish

Fudan University

1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

   Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen +18

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.548033